Sequentia Biotech
Dr. Alfonso Saera-Vila. Head of the transcriptomics consultancy division at Sequentia Biotech.
Sequentia Biotech, an innovative bioinformatics firm, has been at the forefront of genomics since its establishment in 2013. Renowned for its cutting-edge solutions, Sequentia excels in providing comprehensive bioinformatics and software solutions across a spectrum of fields, including diagnostics, drug discovery, medical and academic research, plant biology, and food technologies. By leveraging the potential of omics sciences, Sequentia aims to make meaningful contributions to society.
With a remarkable 15 years of experience in bioinformatics and significant investments in Research and Development (R&D), Sequentia has successfully completed over 700 bioinformatics projects. Serving clients in 63 countries, the company has contributed to over 70 publications in esteemed journals, showcasing an impressive H-index of 130. This outstanding track record underscores Sequentia’s commitment to excellence.
In the Stop Mating project, Sequentia plays a critical role by contributing its expertise in bioinformatics pipeline design and RNA-Seq data analysis and interpretation. The company also leads training efforts by delivering a comprehensive course on RNA-Seq data processing and analysis. Additionally, Sequentia supports knowledge exchange and collaboration by hosting secondments, reinforcing its mission to foster innovation and introduce disruptive technologies in the biotechnology landscape.
Sequentia Biotech, an innovative bioinformatics firm, has been at the forefront of genomics since its establishment in 2013. Renowned for its cutting-edge solutions, Sequentia excels in providing comprehensive bioinformatics and software solutions across a spectrum of fields, including diagnostics, drug discovery, medical and academic research, plant biology, and food technologies. By leveraging the potential of omics sciences, Sequentia aims to make meaningful contributions to society.
With a remarkable 15 years of experience in bioinformatics and significant investments in Research and Development (R&D), Sequentia has successfully completed over 700 bioinformatics projects. Serving clients in 63 countries, the company has contributed to over 70 publications in esteemed journals, showcasing an impressive H-index of 130. This outstanding track record underscores Sequentia’s commitment to excellence.
In the Stop Mating project, Sequentia plays a critical role by contributing its expertise in bioinformatics pipeline design and RNA-Seq data analysis and interpretation. The company also leads training efforts by delivering a comprehensive course on RNA-Seq data processing and analysis. Additionally, Sequentia supports knowledge exchange and collaboration by hosting secondments, reinforcing its mission to foster innovation and introduce disruptive technologies in the biotechnology landscape.
Key Contributions to the Project
- Expertise & guidance on the bioinformatics pipeline design.
- Expertise & guidance on RNAseq data analysis & intepretation.
- RNA-Seq data processing & analysis course.
- Hosting Secondments.
Key Contributions to the Project
- Expertise & guidance on the bioinformatics pipeline design.
- Expertise & guidance on RNAseq data analysis & intepretation.
- RNA-Seq data processing & analysis course.
- Hosting Secondments.